Yisheng Biopharma
Solebury Trout Talks: Interview with David Shao, Yisheng Biopharma - Part of the NameTag Series
Yisheng Biopharma
david_yishen_qs7a66.jpg

Itunes_kzba7m_75awwb_0.jpg

google_podcasts_badge2x_r3ddcn_c8dkjd_0.png

 

Dr. Shao has over 20 years of experience in the biopharmaceutical industry with executive roles in finance, management and business strategy. After eight years as Chief Financial Officer and Global Head of Business, Dr. Shao accepted the role of the President & CEO of Yisheng Biopharma in 2018. Prior to joining Yisheng, Dr. Shao was a principal scientist at Roche conducting drug discovery and technology research. He then became a biotech analyst at Mehta Partners and Kamunting Street Capital. Dr. Shao was Chief Financial Officer of Aoxing Pharmaceutical. Dr. Shao received his Ph.D. in Biochemistry from the University of California San Diego, received his bachelor’s degree from the University of Science and Technology of China and holds an MBA from the Stern School of Business of New York University. Dr. Shao is a certified public accountant (CPA) and is a chartered financial analyst (CFA).